Stockscreener 앱 받기
12.67
0.88%
0.11
시간 외 거래:
12.67
전일 마감가:
$12.56
열려 있는:
$12.45
하루 거래량:
2.88M
Relative Volume:
0.64
시가총액:
$6.26B
수익:
$4.49B
순이익/손실:
$-1.26B
주가수익비율:
-63.35
EPS:
-0.2
순현금흐름:
$425.00M
1주 성능:
+1.28%
1개월 성능:
-13.57%
6개월 성능:
-6.36%
1년 성능:
+31.84%
1일 변동 폭
$12.35
$12.77
1주일 범위
$12.35
$12.83
52주 변동 폭
$9.26
$18.80
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
2500 INNOVATION WAY, GREENFIELD
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Pet Medication Market: Comprehensive Analysis and Key Players-Zoetis, Merck, Merial, Elanco, Bayer. - openPR
ELAN LAWSUIT ALERT: BFA Law Announces Elanco Animal Health has been Sued for Securities Fraud and Urges Investors to Contact the Firm by December 6 Deadline - Newsfile
Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - PR Newswire
The Gross Law Firm Notifies Elanco Animal Health Incorporated In - GuruFocus.com
Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile– Hagens Berman - GlobeNewswire
Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile– Hagens Berman - GlobeNewswire Inc.
Elanco Animal Health (ELAN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
ELAN LAWSUIT ALERT: A Securities Fraud Class Action has - GlobeNewswire
2024-11-04 | ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing
Class Action Filed Against Elanco Animal Health Incorporated (ELAN) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Animal Parasiticides Market Anticipated for Positive Growth - openPR
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elanco Animal - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elanco Animal Health Incorporated Investors to - The Bakersfield Californian
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - PR Newswire
Elanco Animal Health Incorporated (NYSE:ELAN) Position Increased by Harbor Capital Advisors Inc. - MarketBeat
2024-11-03 | ELAN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing
ELAN Investors Have Opportunity to Lead Elanco Animal Health Inc - GuruFocus.com
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus.com
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming DeadlinesELAN - PR Newswire
Private Management Group Inc. Increases Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
ELAN (Elanco Animal Health) Cyclically Adjusted FCF per Sha - GuruFocus.com
ELAN (Elanco Animal Health) Other Current Assets : $904 Mil (As of Jun. 2024) - GuruFocus.com
ELANCO ANIMAL HEALTH has been Sued for Securities Fraud - GlobeNewswire
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit - PR Newswire
Elanco Animal Health Incorporated Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationELAN - PR Newswire
Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile – Hagens Berman - GlobeNewswire
ELAN CLASS ACTION: Elanco Animal Health Investors with - GlobeNewswire
Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
The Gross Law Firm Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - PR Newswire
Raymond James & Associates Sells 777,405 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Levi & Korsinsky Reminds Elanco Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 6, 2024ELAN - PR Newswire
ELAN DEADLINE NOTICE: Elanco Animal Health Investors are - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
White River State Park announces a 15-acre waterfront expansion - INDYtoday
Action Alert: Elanco Securities Class Action Deadline Approaches - CEO Today
White River State Park reveals plans for $65M expansion on stamping plant site - Daily Journal
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Elanco Animal Health (NYSE:ELAN) Price Target Cut to $19.00 - MarketBeat
Europe Companion Animal Health Market Report Analysis - openPR
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 6, 2024 in Elanco LawsuitELAN - PR Newswire
ELAN FRAUD ALERT: BFA Law Notifies Elanco Animal Health - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elanco - GlobeNewswire
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
3.56%
자본화:
|
볼륨(24시간):